PARP Inhibition in the Treatment of Pancreatic Cancer: Current and Future Perspectives on Personalized Therapy

From Clinical Care Options (CCO), downloadable PDF featuring key points from expert discussion on PARP inhibitors in treatment of pancreatic cancer

Eileen M. O'Reilly, MD Naureen Starling, BSc(Hons), MBBS, MD(Res), FRCP Released: May 3, 2022

Video from Clinical Care Options (CCO): Expert insights on biomarker-driven treatment for gastrointestinal (GI) cancers

Pashtoon M. Kasi, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: April 28, 2022 Expired: April 27, 2023

Expert commentary on biomarkers to guide therapy for patients with gastrointestinal cancers, from Clinical Care Options (CCO)

Christopher H. Lieu, MD Released: April 27, 2022

Clinical Care Options (CCO): Experts review key data for gastric, rectal, liver, hepatobiliary tract, and pancreas cancers from the 2022 ASCO Gastrointestinal Cancers Symposium and the ASCO Plenary Series

Manish A. Shah, MD Rachna Shroff, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: April 20, 2022 Expired: April 19, 2023